Erianin alleviates doxorubicin-induced cardiotoxicity by activating the Keap1-Nrf2 signaling pathway
Shiyao Kang, Huimin Li, Ming Li, Yuan Zhao, Jianyu Pang, Juhua Dan, Miaomiao Sheng
Topics & Concepts
CardiotoxicityKEAP1DoxorubicinPharmacologySignal transductionChemistryCancer researchMedicineInternal medicineTranscription factorBiochemistryToxicityChemotherapyGeneOrganic chemistryChemotherapy-induced cardiotoxicity and mitigationCardiac Fibrosis and RemodelingCardiac electrophysiology and arrhythmias